MCQOPTIONS
Saved Bookmarks
| 1. |
In November 2020, whose experimental COVID-19 vaccine has received a fast-track designation from U.S. regulators? |
| A. | Moderna |
| B. | Pfizer |
| C. | Novavax Inc. |
| D. | Emergent BioSolutions |
| E. | Novartis |
| Answer» D. Emergent BioSolutions | |